Skip to main navigation Skip to search Skip to main content

Synthesis, DFT, ADMET and molecular docking studies of thiazole derived thiazolidinone-based chalcone derivatives: alzheimer’s disease current therapies

  • Muhammad Shahid Nadeem
  • , Jalaluddin Azam Khan
  • , Imran Kazmi
  • , Ehssan Moglad
  • , Muhammad Afzal
  • , Sami I. Alzarea
  • , Fazal Rahim
  • , Shoaib Khan
  • , Khushi Muhammad
  • , Gaurav Gupta
  • Faculty of Sciences, King Abdulaziz University
  • Prince Sattam Bin Abdulaziz University
  • Batterjee Medical College
  • Al Jouf University
  • Hazara University
  • Abbottabad University of Science and Technology
  • Saveetha Institute of Medical and Technical Sciences (Deemed to be University)

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Aim: Nitrogen and sulfur-containing compounds are the core components utilized for synthesis of different heterocyclic moieties. Methods & results: In this research, a series of new analogues containing thiazolidinone have been synthesized (1-20) in order to evaluate their activity against acetylcholinesterase and butyrylcholinesterase. Potent analogues were further subjected for molecular docking in order to study their protein-ligand interactions. The highly active analogues were also subjected for DFT, which confirmed the binding properties, electrical properties, and nature with the targeted enzyme. ADMET analysis also confirms the druglikeness properties of the synthesized series. Conclusion: Analog 5 (IC50 = 1.2 ± 0.1 µM and 1.8 ± 0.2 µM) exhibit excellent inhibition in comparison with the standard drug donepezil in view of inhibiting Alzheimer’s disease.

Original languageEnglish
Pages (from-to)649-657
Number of pages9
JournalFuture Medicinal Chemistry
Volume18
Issue number6
DOIs
StatePublished - 2026
Externally publishedYes

Keywords

  • AChE
  • BuChE
  • Synthesis
  • thiazole
  • thiazolidinone & chalcone

Fingerprint

Dive into the research topics of 'Synthesis, DFT, ADMET and molecular docking studies of thiazole derived thiazolidinone-based chalcone derivatives: alzheimer’s disease current therapies'. Together they form a unique fingerprint.

Cite this